2,500 Employees Join Strike Using Annual Leave from May 1 to 5

Concerns Over Production Disruptions Amid Wage and Collective Bargaining Disputes

For the first time since its founding in 2011, Samsung Biologics is facing a full-scale strike.


The labor union will stage a full strike for five days, from May 1, Labor Day, to May 5. The union consists of approximately 4,000 members, accounting for 73% of the company's total workforce as of last year. Among them, more than half—around 2,500 employees—are reported to have expressed their intention to participate in the strike. Instead of organizing separate collective actions during the strike period, the union chose to use annual leave and refrain from work. From May 1 to May 5, Labor Day overlaps with the weekend and Children's Day, so by taking just one day of leave on May 4, employees can have a five-day break. The company explained, "Due to the nature of the strike utilizing vacation days, it is difficult to determine the exact number of participants."

A labor union flag was displayed at the Samsung Biologics factory in Yeonsu-gu, Incheon, on the 30th of last month, one day before the strike by the Samsung Biologics labor union. Photo by Yonhap News Agency

A labor union flag was displayed at the Samsung Biologics factory in Yeonsu-gu, Incheon, on the 30th of last month, one day before the strike by the Samsung Biologics labor union. Photo by Yonhap News Agency

View original image

This strike stems from disagreements between labor and management over wage increases and the restructuring of the personnel system. Since December of last year, the two sides have held 13 rounds of wage and collective bargaining negotiations but failed to reach an agreement. The union is demanding an average wage increase of 14%, a bonus of 30 million won per employee, and allocation of company shares to each employee over three years.


Additionally, the union urged management to reach prior agreements with the union on all matters related to the operation of the personnel system, including recruitment, promotion, and disciplinary action. In contrast, management offered a 6.2% wage increase but stated that it could not accept demands for joint management over personnel and business operations. On the eve of the strike, CEO John Rim held a town hall meeting to apologize to employees and promised to strengthen fairness in the personnel system. On the same day, both parties met through the mediation of the Central Regional Employment and Labor Office but ultimately failed to prevent the full-scale strike.


The areas affected by the full-scale strike include production, quality control (QC), quality assurance (QA), contract development (CDO), and process facilities, except for the materials subdivision work, which underwent a partial strike from April 28 to 30. However, employees in final process departments responsible for preventing drug spoilage and contamination are not participating in the strike. This is in accordance with an injunction issued by the Incheon District Court, which banned industrial action in three processes: concentration and buffer exchange, bulk filling, and related buffer manufacturing and supply. The company maintains that not only these three processes, but all processes—including cell thawing and culture—must be flawlessly controlled for biopharmaceutical production.



The production of biopharmaceuticals is a series of continuous processes based on living cells, and even a minor defect at any stage requires the entire batch to be discarded, regardless of quality issues. Management estimates that if the strike proceeds as planned and disrupts operation of production facilities, the expected losses could reach approximately 640 billion won. In anonymous employee communities, there are claims that batch failures following the partial strike have already resulted in losses exceeding 150 billion won. Samsung Biologics stated, "We are doing our best to minimize production disruptions and customer impact by utilizing all available personnel, but realistically, it will be difficult to completely offset the losses." The union has defined this full-scale strike as the first general strike and indicated that it may embark on further strikes if no agreement is reached between labor and management.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing